Browse By: Country ι Category ι Publisher ι Tag
Home  »  Vaccines

Vaccines Market Research Reports

The global vaccines market is estimated to reach an approximate value of US$44 billion by the year 2017. Vaccines refer to medical preparations that aim at preventing ailments and diseases by stimulating certain immune responses to the diseases. Vaccines are considered to be one of the best inventions of the twentieth century in the field of medicine, because of their effectiveness. Vaccines, in the past have helped in eradicating certain deadly diseases like
ox. However, no vaccine till date can be called 100% effective or perfectly safe. 


There are two main segments in the global vaccines market which are the human vaccine segment and the animal vaccine segment. Human vaccines include adult, adolescent, pediatric, and other vaccines. Some of the popular animal vaccines include livestock, ovine, bovine, feline, canine, equine, porcine, and other vaccines.


The global vaccines market is an integral part of the healthcare and pharmaceuticals market. The vaccines market receives immense support from international organizations, and local governments of various countries in the form of research funds for further development. Innovation in the area of medicines and drugs for human and animal vaccines is the main factor that drives the global vaccines market. The management and logistics aspect of the global vaccines market is determined to a large extent by collaborations between government agencies, large non-profit organizations, and the private sector which includes biotech and pharma companies. 


Lack of innovations in the system of vaccines delivery, greater use of vaccines for prevention of bioterrorism and pandemics, product safety standards, and supply shortages are some of the main problems facing the global vaccines market. 


If you are a player in the global vaccines market, ResearchMoz will help you to formulate the ideal business strategies for future growth and sustenance with its exhaustive collection of research reports on the global vaccines market. ResearchMoz has earned significant reputation in the industry for offering market research reports that are not only accurate but are also pertinent to the prevailing market trends. 

More

Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry : 2014-2018
China is the world\'s largest producer and consumer of pork with the output volume of pork accounting for nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.  The PRRS broke out in southern China and spread rapidly nationwide after summer in 2006, which lead to increases in mortality rate of piglets and pork prices and significant decrease in output volume of pork. In May 2007, the Ministry of Agriculture of China approved the production of highly-pathogenic porcine reproductive and respiratory syndrome inactivated vaccine (NVDC-JXA1) in six manufacturers of biological products. Porcine
Published Date: Sep 2014
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1800
Research Report on China Swine Fever Vaccine Industry : 2014-2018
China is the world\'s largest producer and consumer of pork with the output volume accounting nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.  Swine fever is considered a highly infectious disease that needs strict prevention, control and extermination. The swine fever vaccine is one of the necessary vaccines for pigs. Due to the mature technology of swine fever vaccines in China, most large-scale pig farms choose domestic vaccines instead of imported vaccines. There are 48 manufacturers of spleen neisseria vaccines and cell vaccines in China, including 32 for the former and 41 for t
Published Date: Sep 2014
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1800
Research Report on China Foot-and-mouth Disease (FMD) Vaccine Industry : 2014-2018
China is the world\'s largest producer and consumer of pork with the output volume accounting nearly 50% of the total. According to the statistics of agricultural production from the National Bureau of Statistics of China, the annual output volume of poultry meat was 83.73 million tons in 2013, up by 1.8% YOY. The output volume of pork was 54.93 million tons, up by 2.8%. The stock volume of hogs was 474.11 million, down by 0.4% compared to 2012. The stock volume of fattened hogs was 715.57 million, up by 2.5% compared to 2012. In 2012, serious Type-A FMD broke out in Guangdong, Henan and Anhui. In 2013, Type-A FMD occurred in Guangxi and Guangdong. Therefore, it is necessary to inoculate pigs, cattle and sheep against FMD.  According to the National Compulsory Immunization Plan of
Published Date: Sep 2014
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1800
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for vaccines   The report provides a detailed understanding and analysis of how and why companies enter vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative
Published Date: Jul 2014
Published By: Current Partnering

Price: $2995
Global Cigar market: Trends & Opportunities (2014-2018)
Scope of the Report The report titled “Global Cigar Market: Trends and Opportunities (2014-2018)” provides an in-depth analysis of major cigar markets of China, United States, Germany, Spain, the UK and China. It also accesses the key opportunities and underlying trends in the market and outlines the factors that are and will be driving the growth of the industry in the forecasted period (2014-18). Further, key players of the industry like Imperial Tobacco, Habanos and Swedish Match have been profiled. Geographical Coverage United States Germany Spain The UK China Company Coverage Swedish Match Imperial tobacco Habanos Executive Summary The cigar market, in the recent years, had to face the brunt of global economic downturn. Currentl
Published Date: Jun 2014
Published By: Daedal Research

Price: $850
Vaccines Markets in China
China\'s demand for Vaccines has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China\'s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented. Major producers in China are profiled.
Published Date: May 2014
Published By: Asia Market Information & Development Company

Price: $4000
Global Influenza (Flu) Vaccine Market: Trends & Opportunities (2014-19)
With the advancement in technology and discovery of new products in the field of medical sciences, vaccines have gained crucial position in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed, saving innumerable lives. The vaccine market is growing at a steady pace, mainly because of the various existing and emerging diseases which can only be prevented with the help of vaccines. Scientists are continuously engaged in the research and development of effective vaccines to eradicate all major life threatening diseases. There are various organizations namely the Global Alliance for Vaccines and Immunizations (GAVI), World Health Organization (WHO), the World Bank, the United Nations Children\'s Fund (UNICEF) and Bill and Melinda Gate
Published Date: Apr 2014
Published By: Daedal Research

Price: $800
Meningococcal Vaccines Market (Polysaccharide, Conjugate, and Combination Vaccines, along with Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
The global meningococcal vaccines market is studied on the basis of vaccine types such as polysaccharide, conjugate and combination vaccines. The vaccine types are further segmented into different brands. The report also highlights and analyzes various brands under pipeline segment, namely, Bexsero, MnB rLP2806 and NmVac-4DT. A detailed market analysis and forecast for these segments has been provided in this study, in terms of revenue (USD million) for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each meningococcal vaccine segment and brand for the forecast period 2013 to 2019, while market size estimations have been made considering 2011 and 2012 as the base years.  In terms of geographical distribution, the global meningococc
Published Date: Apr 2014
Published By: Transparency Market Research

Price: $4795
Global and China Recombinant Hepatitis B Vaccine (Hansenula polymorpha) Industry 2014 Market Research Report
The report firstly introduced Recombinant Hepatitis B Vaccine(Hansenula polymorpha) basic information included Recombinant Hepatitis B Vaccine(Hansenula polymorpha) definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Recombinant Hepatitis B Vaccine(Hansenula polymorpha) industry policy and plan, Recombinant Hepatitis B Vaccine(Hansenula polymorpha) product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Recombinant Hepatitis B Vaccine(Hansenula polymorpha) capacity production cost price profit production value gross margin etc details information, at the sa
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Influenza Vaccine (Split Virion),Inactivated Industry 2014 Market Research Report
The report firstly introduced Influenza Vaccine (Split Virion),Inactivated basic information included Influenza Vaccine (Split Virion),Inactivated definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Influenza Vaccine (Split Virion),Inactivated industry policy and plan, Influenza Vaccine (Split Virion),Inactivated product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Influenza Vaccine (Split Virion),Inactivated capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Influ
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
In-depth Research on China Animal Vaccine Industry, 2014
At present, there are 88 animal vaccine manufacturers in China, with 338 production lines. But most of enterprises are small in scale, vaccine production inspection is not standard and product structures are not reasonable. Market shares are occupied by a minority of enterprises. According to the statistics by China Veterinary Drug Association (CVDA), the production capacity of live vaccines was 344.58 billion doses in 2012; the production capacity of inactivated vaccines was 55.392 billion milliliters; in China\'s animal vaccine industry, the annual sales revenue reached CNY 8.888 billion in 2012, and the top 10 enterprises as for sales revenue accounted for 50% of total sales revenue of biological products. Among the key animal vaccine manufacturers in China in 2012, China Animal H
Published Date: Feb 2014
Published By: Huidian Research

Price: $2200
Global and China Tetanus Vaccine Adsorbed Industry 2014 Market Research Report
The report firstly introduced Tetanus Vaccine Adsorbed basic information included Tetanus Vaccine Adsorbed definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Tetanus Vaccine Adsorbed industry policy and plan, Tetanus Vaccine Adsorbed product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Tetanus Vaccine Adsorbed capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Tetanus Vaccine Adsorbed products customers application capacity market position company contact informat
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Measles Vaccine Live Industry 2014 Market Research Report
The report firstly introduced Measles Vaccine Live basic information included Measles Vaccine Live definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Measles Vaccine Live industry policy and plan, Measles Vaccine Live product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Measles Vaccine Live capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Measles Vaccine Live products customers application capacity market position company contact information etc company related
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Influenza Vaccine (Whole Virion),Inactivated Industry 2014 Market Research Report
The report firstly introduced Influenza Vaccine (Whole Virion),Inactivated basic information included Influenza Vaccine (Whole Virion),Inactivated definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Influenza Vaccine (Whole Virion),Inactivated industry policy and plan, Influenza Vaccine (Whole Virion),Inactivated product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Influenza Vaccine (Whole Virion),Inactivated capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Influ
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Hepatitis A and B Combined Vaccine Industry 2014 Market Research Report
The report firstly introduced Hepatitis A and B Combined Vaccine basic information included Hepatitis A and B Combined Vaccine definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Hepatitis A and B Combined Vaccine industry policy and plan, Hepatitis A and B Combined Vaccine product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Hepatitis A and B Combined Vaccine capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Hepatitis A and B Combined Vaccine products customers a
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China Swine Vaccine Industry 2014 Market Research Report
The report firstly introduced Swine Vaccine basic information included Swine Vaccine definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, Swine Vaccine industry policy and plan, Swine Vaccine product specification, manufacturing process, cost structure etc. then statistics Global and China key manufacturers Swine Vaccine capacity production cost price profit production value gross margin etc information, and Global and China Swine Vaccine capacity production market share supply demand shortage import export consumption etc data statistics, and Swine Vaccine 2009-2014 capacity production price cost profit production value gross margin etc i
Published Date: Feb 2014
Published By: QYResearch

Price: $2200
Global and China H1N1 Vaccines Industry 2014 Market Research Report
The report firstly introduced H1N1 Vaccines basic information included H1N1 Vaccines definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis, H1N1 Vaccines industry policy and plan, H1N1 Vaccines product specification, manufacturing process, cost structure etc. then statistics Global and China key manufacturers H1N1 Vaccines capacity production cost price profit production value gross margin etc information, and Global and China H1N1 Vaccines capacity production market share supply demand shortage import export consumption etc data statistics, and H1N1 Vaccines 2009-2014 capacity production price cost profit production value gross margin etc i
Published Date: Jan 2014
Published By: QYResearch

Price: $2200
China Influenza Vaccine Industry 2014 Deep Research Report
Firstly the report describes the background knowledge of Influenza Vaccine, including Concepts Classification Manufacturing process technical parameters and equipments List etc; then statistics International and China 16 Manufacturers Influenza Vaccine product 2009-2017 Capacity production cost price production value profit margins and other relevant data, statistics these enterprises Influenza Vaccine products, Product Specifications, company background information, then summary statistics and analysis the relevant data on these enterprises. The report got Global and China Influenza Vaccine companies production market share, China Influenza Vaccine demand supply and shortage,  China Influenza Vaccine 2009-2017 production price cost profit production value profit margins, production
Published Date: Jan 2014
Published By: QYResearch

Price: $2200
Infectious Vaccines Partnering Terms and Agreements
The Infectious Vaccines Partnering Terms and agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.  The report also includes adjuvant deals and alliances.   This report provides details of the latest infectious vaccines agreements announced in the healthcare sectors.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect
Published Date: Dec 2013
Published By: Current Partnering

Price: $1995
Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis
World Adult Vaccines Market – Market Overview   For much of the 20th century, vaccines were a pharmaceutical success story largely associated with children. Aggressive immunization programs eradicated Polio and Smallpox among developed nations and nearly eliminated Mumps, Pertussis, Measles, and other diseases. While Pediatric Vaccines are an important market, it is now adults who are fueling growth of vaccine products. The world adult vaccines market is expected to nearly double by 2020 from the current figure of 2012.    Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention. As a result, vaccine preventable diseases and their resulting deaths are now rare in the developed
Published Date: Nov 2013
Published By: Renub Research

Price: $1990
Cancer Vaccine Partnering Terms and Agreements
The Cancer Vaccine Partnering Agreements Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies. The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in cancer vaccine partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer vaccine partnering contract documents Top cancer vaccine deals by value  The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and
Published Date: Nov 2013
Published By: Current Partnering

Price: $1995
Research Report on China Avian Influenza Vaccine Industry, 2013 - 2017
In the current stage, many countries choose to cull all infected poultry to control avian influenza, instead of immunizations. The total volume of the poultry in China is over 10 billion, but more than 90% raisers only have less than 2,000 broilers. In case of epidemic diseases, it is hard to control them, which will result in huge losses. Therefore, it is quite necessary to immunize the poultry with avian influenza vaccines.  Avian influenza vaccines have been used for more than 10 years in China. More than 10 years ago, some poultry raising farms in China used the H5N1 avian influenza vaccine. They were not forced but voluntary to use vaccines. Between 2001 and 2005, when China avian influenza vaccine industry just started, various problems frequently emerged. To resolve these
Published Date: Oct 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1300
Research Report on China Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry, 2013 - 2017
In China, PRRS is the most serious disease that impairs the pig raising & breeding industry. It inflicted heavy losses on China pig raising & breeding industry for many times.  In April 2007, Ministry of Agriculture of China issued Technical Standards of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Prevention and Treatment, and classified HP-PRRS into serious animal epidemic diseases which are covered by the national compulsory immunization program. Based on National Compulsory Immunization Plan of Animal Epidemic Diseases 2013, China government conducts compulsory vaccinations for all pigs against HP-PRRS. In order to identify various strains, local governments must take effective measures and ensure every county only use one kind of live HP-PRRS vacci
Published Date: Oct 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1300
Research Report on China Swine Fever Vaccine Industry, 2013 - 2017
Swine fever is an acute, hyperpyretic and contagious disease, caused by swine fever viruses. Its incidence rate and death rate are both extremely high, and viruses can be transmitted at high speed. Immunization is the major measure to prevent swine fever.  With the development of Chinese economy and increasing living standards of Chinese people, the demand for pork keeps growing accordingly. In 2012, the output volume of pork in China was 53.35 million tons, increasing by 5.6% YOY. The fattened volume of pigs in 2012 was 696.28 million, increasing by 5.2% YOY. With the expansion of the pig raising industry, farmers in China have an increasing demand for swine fever vaccines.  In 2007, Chinese government started to conduct compulsory immunizations against swine fever, Acco
Published Date: Oct 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1300
Research Report on China Foot and Mouth Disease (FMD) Vaccine Industry, 2013-2017
Foot-and-mouth disease is prevalent in many countries. Since 1980s, animal husbandry has been developing rapidly in China. Because the breeding methods of Chinese farmers are rather laggard, the prevention and control system of animal epidemic diseases is not complete and FMD is popular in the neighboring countries, FMD is always a huge threat to China animal husbandry. FMD mainly has seven serotypes including Type A, Type O, Type C, Type Asia I, Type South Africa I, Type South Africa II, Type South Africa III, etc. Cloven-hoofed animals like cattle, sheep, pigs, camels and so on are easy to be infected by FMD. In 2004, Type Asia I FMD was transmitted into China. As a result, FMD occurred in China in 2004-2008 all belongs to this type. Because it has rapid spreading speed and high inf
Published Date: Oct 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1200
Research Report on Chinas Haemophilus Influenza B (HIB) Vaccine Industry, 2013-2017
Haemophilus influenza type B is a kind of haemophilus influenza with extremely strong invasiveness. Among all the serious infections caused by haemophilus influenzas, almost 90% were caused by haemophilus influenza type B. According to the researches in recent years, HIB has become the first bacteria that will cause diseases on the respiratory tracts of children in China. It mainly causes lower respiratory infection and pneumonia. After infected by HIB, the risk of getting invasive diseases is related to one\'s HIB immune level. The prevalence rate of HIB antibody in infants is quite high, which mainly comes from mothers. Antibody titer reaches the highest point when infants are three to four months old. In addition, because infants are naturally exposed to HIB or other pathogenic bac
Published Date: Sep 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1200
Research Report on China Human Rabies Vaccine Industry, 2013-2017
In recent years, with increasing number of pets and the lack of strict pet management, the incidence trend of rabies in China is not optimistic. According to the survey data provided by Chinese Centers for Disease Control and Prevention (CDC), there were 130 million dogs in China by April 2012, ranking the first around the world. The death rate is approximate to 100% if people are infected with rabies viruses and contract rabies. In China, in more than 95% rabies cases, people are attacked by rabies as they are bitten by dogs.  The problem of rabies is essentially the problem of quantity control of dogs. According to incomplete statistics, the total number of people injured by animals in 2012 was more than 40 million person-times. Most of them were bitten by dogs. In 2012, the in
Published Date: Sep 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1200
Research Report on China Measles, Mumps and Rubella (MMR) Vaccine Market, 2013-2017
Measles, mumps and rubella are major infectious diseases that threaten the health of children. Measles is a kind of acute respiratory infectious disease caused by measles virus with rashes covering the whole body. Mumps is a kind of respiratory infectious disease caused by mumps virus, which can violate organs including various gland tissues, nervous system, liver, kidney, heart, joint, etc. Rubella is a kind of acute respiratory infectious disease caused by rubella virus with light constitutional symptoms and lymphadenectasis behind the ears and on the necks, without koplik spots. In China, the incidence rate of measles declines constantly in recent years. In 2012, the number of measles patients was 6,183, decreasing by 37.82% YOY, with eight patients died of measles. In 2012, the in
Published Date: Sep 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $1200
China Human Vaccine Industry Report, 2012-2015
In the wake of China\'s economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5 billion with the lot release quantity of roughly 773 million person-portions. Restricted by China\'s national conditions and policies, EPI vaccines still prevail in China and Chinese EPI vaccine market is almost monopolized by state-run enterprises represented by CNBG Tiantan Biological, Biological Products Institutes in Changchun, Chengdu, Wuhan, Shanghai and Lanzhou, and Institute of Medical Biology of Chinese Academy of Medical Sciences in Kunming. In 2012, state-owned enterprises seized 81.5% of the vaccine lot release quantity in Chinese EPI vaccine market. However, along with the gradual relaxed a
Published Date: Aug 2013
Published By: Research In China

Price: $2500
Research Report on Global and China Human Vaccine Industry, 2013-2017
The research object of the report is human vaccines. According to different types and sources, vaccines can be divided into pathogenic protein vaccine, recombinant protein vaccines, immune protein vaccines and gene vaccines.  In China, vaccines are generally divided into Vaccine I and Vaccine II. Vaccine I is offered for free, and it\'s priced and purchased uniformly by the government, covering the major epidemic diseases of Hepatitis B, epidemic cerebrospinal meningitis, Tetanus, etc. Vaccine II is other vaccines inoculated voluntarily at residents\' own expense. It is independently priced and has large profit margins, but there are intense competition in the market. The frequentlyused Vaccine II includes Pneumonia vaccine, Varicella Vaccine, Type B Haemophilus Influenzae Conjugat
Published Date: Aug 2013
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $2200
Research Report on Dairy Cattle Vaccine Market in China
Research Background In the past few years, dairy farming has been developing rapidly in China. Especially dairy farms above 100 head inventory have been established in large number. Simultaneously, the farming models like dairy farming community and dairy cooperative also presented good performance. In 2012, China dairy cattle inventory reached 14.2 million heads, among which 25% are covered by farms with inventory of over 500 heads. With increase of farming density, dairy farming in China is threatened by increasing incidence of diseases. Vaccines, as a kind of major livestock and poultry disease prevention measure, are in huge demand. Especially commercial vaccines with high safety and sound immune effect are well accepted by industrial dairy farms.  Foot-and-mouth dise
Published Date: Jun 2013
Published By: Beijing Shennong Kexin Agribusiness Consulting Co. Ltd

Price: $4180
China Animal Vaccine Industry Report, 2012-2015
In view of the frequent occurrence of animal epidemic diseases over the years, the Chinese government has increased investment in epidemic prevention and implemented compulsory immunization system. Beginning in 2004, it has gradually included highly pathogenic avian influenza, highly pathogenic PRRS (porcine reproductive and respiratory syndrome), classical swine fever and peste des petits ruminants in the national compulsory immunization coverage following the FMD (foot-and-mouth disease), thus leading to rapid growth in animal vaccine market size.  In 2004-2012, China’s animal vaccine market size grew at a CAGR as high as 26.4%, up to approximately RMB 9.1 billion in 2012 (including net import). For years to come, the market is expected to continue to maintain a growth ra
Published Date: Jun 2013
Published By: Research In China

Price: $2400
Global Vaccine Market to 2017 - Market Size, Growth, and Forecasts in Over 70 Countries
Global Vaccine Market to 2017 - Market Size, Growth and Forecasts in Over 70 Countries is a comprehensive publication that enables readers the critical perspectives to be able to evaluate the world market for vaccines. The publication provides the market size, growth, and forecasts at the global level as well as for each of the following countries: Argentina, Armenia, Australia, Austria, Azerbaijan, Bangladesh, Belgium, Bolivia, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Ethiopia, Finland, France, Georgia, Germany, Ghana, Greece, Hungary, India, Indonesia, Iran, Ireland, Italy, Japan, Jordan, Kazakhstan, Kyrgyzstan, Latvia, Lebanon, Lithuania, Macedonia, Malaysia, Mexico, Moldova, Mongolia, Morocco, Nepal, Netherlands, Nigeria, Norway, Om
Published Date: Jun 2013
Published By: MarketSizeInfo

Price: $2570
Infectives Vaccine Partnering Terms and Agreements
The Infectives vaccine partnering terms and agreements report provides a detailed understanding and analysis of how and why companies enter infectives vaccine partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report also includes adjuvant deals and alliances.   This report provides details of the latest infectives vaccine agreements announced in the healthcare sectors.   Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achi
Published Date: Jun 2013
Published By: Current Partnering

Price: $1995
Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth
The leading business intelligence provider GBI Research has released its latest research report, entitled “Travel Vaccines Market to 2019 – Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth”. The report provides insights into the vaccines in the Travel Vaccines market including market forecasts up to 2019. It provides an in-depth analysis of the travel vaccines, as well as insights into the Travel Vaccines R&D pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global Travel Vaccines market.  The report analyzes the market for Travel Vaccines in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. In addition, it provides overv
Published Date: May 2013
Published By: GBI Research

Price: $3500
Strategic Overview of Global Preventable Vaccine Market 2012-2016
TechNavio's analysts forecast the Strategic Overview of Global Preventable Vaccine Market to grow at a CAGR of 8.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in demand for vaccination. The Strategic Overview of Global Preventable Vaccine market has also been witnessing the trend of increase in market consolidation. However, the emergence of regional players could pose a challenge to the growth of this market. TechNavio's report, the Strategic Overview of Global Preventable Vaccine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Strategic Overview of Global Preventable Vaccine Market
Published Date: Apr 2013
Published By: Technavio

Price: $3000
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants
Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants which essentially provides insights into the seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2018. The report also delves deep into vaccination patterns for seasonal influenza in the Asia-Pacific Region. Further, the geographical distribution of seasonal influenza vaccines across Japan, Australia, New Zealand, China, Taiwan, Philippines, Hong Kong, Malaysia, India and Singapore are also provided in the report.  The report offers a clear view of the regulatory landscape in the Asia-Pacific countries. The report also reveals the seasonal influenza vac
Published Date: Apr 2013
Published By: GBI Research

Price: $3500
Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake
Therapeutic Cancer Vaccines Market to 2019 Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake Summary GBI Research, the leading business intelligence provider, has released its latest research “Therapeutic Cancer Vaccines Market to 2019 Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake”. There is currently only one marketed therapeutic cancer vaccine, Provenge, which is indicated for the treatment of castrate resistant, asymptomatic metastatic prostate cancer which achieved global sales of approximately $215 million in 2011.  Over the forecast period, numerous vaccines are anticipated to be approved over a range of indications including the commonly diagnos
Published Date: Mar 2013
Published By: GBI Research

Price: $3500
China Varicella Vaccine Industry 2013 Deep Research Report
This report has firstly introduced Varicella Vaccine definition classification industry chain etc related information. Then introduced Varicella Vaccine manufacturing technology and product specifications, And then summary statistics China major Varicella Vaccine manufacturers 2010-2016 Varicella Vaccine capacity production supply demand shortage and Varicella Vaccine selling price cost gross margin and production value, and also introduced China 5 manufacturers company basic information, 2010-2016 Varicella Vaccine capacity production price cost gross margin production value China market share etc details information.  In the end, this report introduced 4 Million Bottles/year Varicella Vaccine project feasibility analysis and investment return analysis, also give related resea
Published Date: Mar 2013
Published By: QYResearch

Price: $1500
China Japanese Encephalitis Vaccine Industry 2013 Deep Research Report
This report has firstly introduced Japanese Encephalitis Vaccine definition classification industry chain etc related information. Then introduced Japanese Encephalitis Vaccine manufacturing technology and product specifications, And then summary statistics China major Japanese Encephalitis Vaccine manufacturers 2010-2016 Japanese Encephalitis Vaccine capacity production supply demand shortage and Japanese Encephalitis Vaccine selling price cost gross margin and production value, and also introduced China 5 manufacturers company basic information, 2010-2016 Japanese Encephalitis Vaccine capacity production price cost gross margin production value China market share etc details information.  In the end, this report introduced 4Million Doses/year Japanese Encephalitis Vaccine pro
Published Date: Mar 2013
Published By: QYResearch

Price: $1400
China Human Rabies Immunoglobulin Industry 2013 Market Research Report
The report firstly introduced Human Rabies Immunoglobulin basic information included Human Rabies Immunoglobulin definition classification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Human Rabies Immunoglobulin industry policy and plan, Human Rabies Immunoglobulin product specification, manufacturing process, product cost structure etc. then statistics China key manufacturers Human Rabies Immunoglobulin capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Human Rabies Immunoglobulin products customers application capacity market position company contact
Published Date: Feb 2013
Published By: QYResearch

Price: $2000
China Swine Vaccine Market Analysis Report
Research Background By 2011, the swine output in China has increased from 2006’s 610 million heads to 660 million heads. Meanwhile, the proportion of scaled swine farming is also expanding gradually. In recent years, the sales value of animal health products in China has been increasing with an annual growth rate of 15-17%. Currently, the sales value of bioproducts for swine is about 1.8-2.0 billion RMB/year, accounting for about 37% of bioproducts sales value and about 7% of animal health products market share (estimated according to “Veterinary Drug Industry Report 2009). With the steady expansion of swine farming inventory and scaled farming proportion, swine vaccines (especially commercial vaccines) sales volume will continue to increase in the next 5 years.
Published Date: Feb 2013
Published By: Beijing Shennong Kexin Agribusiness Consulting Co. Ltd

Price: $8800
Research on Chinas Animal Vaccine Industry, 2013-2017
Animal vaccine sales amount in China was about CNY 7.11 billion (excluding net imports); the sales amount of swine vaccine and poultry vaccines were CNY 3.51 billion and 3.01 billion respectively, accounting for 49.4% and 42.3% of the total sales amount respectively. The market scale of China\'s animal vaccine is nearly CNY 10 billion in 2012. Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few corporations. CAHIC, Qingdao Yebio Bioengineering Co. Ltd., Dahuanong, TECON and Chengdu TECBOND are the representatives of China’s animal vaccine industry. The five enterprises accounted for 37.9% of China’s animal vaccine market in the first half of 2012. Among the key animal vaccine manufacturers in China,
Published Date: Jan 2013
Published By: Huidian Research

Price: $2100
China Human Immunoglobulin (pH4) for Intravenous Injection Industry Research Report 2013
This report has firstly introduced Human Immunoglobulin (pH4) for Intravenous Injection definition classification industry chain etc related information. Then introduced Human Immunoglobulin (pH4) for Intravenous Injection manufacturing technology and product specifications, And then summary statistics China major Human Immunoglobulin (pH4) for Intravenous Injection manufacturers 2010-2016 Human Immunoglobulin (pH4) for Intravenous Injection capacity production supply demand shortage and Human Immunoglobulin (pH4) for Intravenous Injection selling price cost gross margin and production value, and also introduced China 25 manufacturers company basic information, 2010-2016 Human Immunoglobulin (pH4) for Intravenous Injection capacity production price cost gross margin production value Ch
Published Date: Jan 2013
Published By: QYResearch

Price: $2000
China Human Use Rabies Vaccine Industry 2013 Deep Research Report
This report has firstly introduced Human Use Rabie Vaccine definition classification industry chain etc related information. Then introduced Human Use Rabie Vaccine manufacturing technology and product specifications, And then summary statistics China major Human Use Rabie Vaccine manufacturers Human Use Rabie Vaccine (Hamster Kidney Cell) Human Use Rabie Vaccine (Vero) Human Use Rabie Vaccine (Chicken Embryo Cell) 2010-2016 Human Use Rabie Vaccine capacity production supply demand shortage and Human Use Rabie Vaccine selling price cost gross margin and production value, and also introduced China 16 manufacturers company basic information, 2010-2016 Human Use Rabie Vaccine capacity production price cost gross margin production value China market share etc details information. In
Published Date: Jan 2013
Published By: QYResearch

Price: $2000
China Hepatitis B Vaccine Industry 2013 Deep Research Report
This report has firstly introduced Hepatitis B Vaccine definition classification industry chain etc related information. Then introduced Hepatitis B Vaccine manufacturing technology and product specifications, And then summary statistics China major Hepatitis B Vaccine manufacturers 2009-2013 Hepatitis B Vaccine capacity production supply demand shortage and Hepatitis B Vaccine selling price cost gross margin and production value, and also introduced China 8 manufacturers company basic information, 2009-2013 Hepatitis B Vaccine capacity production price cost gross margin production value China market share etc details information.  In the end, this report introduced 10million pieces/year Hepatitis B Vaccine project feasibility analysis and investment return analysis, also give
Published Date: Jan 2013
Published By: QYResearch

Price: $2000
Indian Vaccine Industry: Trends & Opportunities (2012-2017)
With the advancement in technology and discovery of new products in medical sciences, vaccines are proved crucial and effective in the pharmaceutical industry. Vaccines are considered as the most effective health intervention ever developed. Vaccine has saved innumerable lives up till now and continues to do so in the future also. Vaccine industry is growing popularity mainly because of the various existing and emerging diseases which can be prevented with the help of vaccines. Scientists continuously perform research and development so that they can come up with new vaccine that can cure diseases. There are various organizations namely The Global Alliance for Vaccines and Immunizations (GAVI), World Health Organization (WHO), the World Bank, UNICEF and Bill and Melinda Gates founda
Published Date: Dec 2012
Published By: Daedal Research

Price: $800
Global H1N1 Vaccines Market 2011-2015
TechNavio\'s analysts forecast the Global H1N1 Vaccines market to decline at a CAGR of -33 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased awareness among people in developed nations. The Global H1N1 Vaccines market has also been witnessing the trend of Pre-pandemic vaccinations. However, the easing pandemic situation could pose a challenge to the growth of this market.  TechNavio\'s report, the Global H1N1 Vaccines Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global H1N1 Vaccines market landscape and its growth prospects in the coming years. The report also includes a discu
Published Date: Nov 2012
Published By: Technavio

Price: $1500
Chinese Markets for Vaccines
China's demand for vaccines has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2001, 2006 and 2011) and long-term forecasts through 2016 and 2021 are presented. Major producers in China are profiled.
Published Date: Oct 2012
Published By: Asia Market Information & Development Company

Price: $2000
Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019
GlobalData, the industry analysis specialist, has released its new report, Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of information and analysis on the global Hepatitis A Preventive Vaccines market. The report identifies the key trends shaping and driving the global Hepatitis A Preventive Vaccines market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hepatitis A Preventive Vaccines sector. This report is built using data and information sourced from proprietary databases, primary
Published Date: Jun 2012
Published By: GlobalData

Price: $3995
China Influenza Vaccine Industry 2012 Deep Research Report
Firstly the report describes the background knowledge of Influenza Vaccine, including Concepts Classification Manufacturing process technical parameters and equipments List etc; then statistics International and China 16 Manufacturers Influenza Vaccine product 2009-2016 Capacity production cost price production value profit margins and other relevant data, statistics these enterprises Influenza Vaccine products, Product Specifications, company background information, then summary statistics and analysis the relevant data on these enterprises.  The report got Global and China Influenza Vaccine companies production market share, China Influenza Vaccine demand supply and shortage, China Influenza Vaccine 2009-2016 production price cost profit production value profit margins, produ
Published Date: May 2012
Published By: QYResearch

Price: $2200
Research Report on Chinese Human Vaccine Industry, 2012
The research object of the report is human vaccine apart from animal vaccine. Vaccination is the most economical, effective, safe and convenient way to prevent disease and the investment of vaccination is far more less than that of the treatment. Hence, it is of significance to make great contribution to save social resources.  In China, vaccine is customarily divided into vaccine I and Vaccine II. Vaccine I is offered for free, and it\'s priced and purchased uniformly by government, covering the major epidemic diseases of Hepatitis B, Idemic Encephalitis, Tetanus, etc. Vaccine II is that vaccine which is inoculated voluntarily at people\'s own expense. It is independently priced and has large profit margins, but there are intense competitions in the market. The frequently-used
Published Date: Mar 2012
Published By: China Research and Intelligence Co., Ltd. (CRI)

Price: $3000
Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms
GBI Research, the leading business intelligence provider, has released its latest research, “Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms”. The report analyzes the markets for veterinary vaccines, covering bovine, ovine, porcine and equine species in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain), and Japan. The report also provides geographical landscape, competitive landscape, product profiles, and analysis on drivers and barriers that impact the veterinary vaccines market. Furthermore, the report provides company profiling, SWOT analysis for the leading companies, and analyzes the mergers, acquisitions, recent activitie
Published Date: Jan 2012
Published By: GBI Research

Price: $3500
Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
GBI Research, the leading business intelligence provider, has released its latest research, Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market, which provides insights into the global emerging cancer vaccines market and a market forecast until 2017. The report provides an in-depth analysis of the five therapeutic indications for which vaccines are available in the market or which have a promising vaccine in Phase III of their pipeline.  In addition, the report also includes various types of cancer vaccine development and vaccine delivery methods along with a case study, advantages and disadvantages for each type, insights into the cancer vaccines R&D pipeline, SWOT profil
Published Date: Oct 2011
Published By: GBI Research

Price: $3500
Vaccine Pipeline Database: 1-Year Subscription
Vaccine Pipeline Database: 1-Year Subscription Product description Subscription to La Merie’s proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of vaccines is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed.  The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. An advanced search function allows to combine search
Published Date: Oct 2011
Published By: La Merie Publishing

Price: $1287
Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010
GBI Research, the leading business intelligence provider, has released its latest research, Adult and Adolescent Vaccines Market to 2017 - Partnerships Increase as Licensing and Co-Development Account for 73% of all Deal-Making Activity in 2010, which provides insights into the global vaccines market, forecast until 2017. The report provides an in-depth analysis of five vaccines, which include pneumococcal, seasonal flu, human papillomavirus, hepatitis A and hepatitis B. The report also examines the immunization schedules for the covered vaccines. In addition, the report also includes insights into the vaccines R&D pipeline.  The report is built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GBI
Published Date: Aug 2011
Published By: GBI Research

Price: $3500
China Human Vaccine Industry Report, 2010-2011
With the improvement of economy and peoples disease prevention awareness, Chinas human vaccine market has expanded in recent years, growing at a CAGR of 24.0% in 2007-2010. In particular, the market scale in 2010 hit RMB10.3 billion, up 14.4% year-on-year. Under the influence of Chinas actual conditions and the vaccine industry characteristics, state-owned human vaccine enterprises take a lions share in the market, especially in the EPI (Expanded Program on Immunization) vaccines market. In terms of lot release quantity, state-owned enterprises occupied 68.1% of the extra EPI vaccines market in 2010. For example, meningococcal vaccines and hepatitis A vaccine are mainly offered by stated-owned enterprises including 6 research institutions under China National Biotec Group and Kunming Branc
Published Date: May 2011
Published By: Research In China

Price: $2200